Caspase activation without apoptosis: insight into A beta initiation of neurodegeneration

New work in a mouse model of Alzheimer's disease suggests that early-stage synaptic and memory impairments are caused by abnormal activation of a protease and a phosphatase, both of which could be targeted by inhibitory drugs.